https://www.selleckchem.com/pr....oducts/sirpiglenasta
5 vs. 89.0 days). CONCLUSIONS Specific mutations in inhA and katG are associated with differences in resistance to other drugs and TSCC. Molecular testing may make it possible to tailor treatment and assess additional drug resistance risk according to specific mutation profile. Published by Oxford University Press for the Infectious Diseases Society of America 2020. This work is written by (a) US Government employee(s) and is in the public domain in the US.BACKGROUND Long-term consequences of mild subclinical hypothyroidism (SH)
Like
Comment
Share
